HEALTHCARE NEWS OPTIONS

Healthcare News Options

FTC sues major pharmacy reward managers around insulin price ranges The company brought action against Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the listing cost of existence-preserving insulin medicine.Never skip tomorrow's healthcare sector news Permit

read more